Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia

BACKGROUND: Aripiprazole has been reported to worsen psychotic symptoms when switching from other antipsychotics, possibly due to dopamine supersensitivity psychosis. OBJECTIVE: This study aimed to explore the predictors and possible underlying mechanisms of aripiprazole-related psychotic exacerbati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chia-Hao, Chan, Hung-Yu, Hsieh, Ming H., Liu, Chen-Chung, Liu, Chih-Min, Hwu, Hai-Gwo, Kuo, Ching-Hua, Chen, Wei J., Hwang, Tzung-Jeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801645/
https://www.ncbi.nlm.nih.gov/pubmed/35111295
http://dx.doi.org/10.1177/20451253211064396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801645/
https://www.ncbi.nlm.nih.gov/pubmed/35111295
http://dx.doi.org/10.1177/20451253211064396

Ejemplares similares